tiprankstipranks
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd.
RESEARCH TOOLSreports

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Ratios

2 Followers

Jagsonpal Pharmaceuticals Ltd. Ratios

IN:JAGSNPHARM's free cash flow for Q2 2026 was ₹0.63. For the 2026 fiscal year, IN:JAGSNPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.23. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 6.07 6.22 10.42 5.97 4.04
Quick Ratio
 5.59 5.64 9.63 5.22 2.94
Cash Ratio
 0.38 4.97 0.67 0.40 0.93
Solvency Ratio
 1.08 1.66 0.81 0.77 0.54
Operating Cash Flow Ratio
 0.74 2.13 1.84 1.69 0.21
Short-Term Operating Cash Flow Coverage
 14.98 0.00 0.00 61.88 0.00
Net Current Asset Value
₹ 1.56B₹ 1.23B₹ 1.70B₹ 1.29B₹ 714.82M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.04 0.03 0.03
Debt-to-Equity Ratio
 0.03 0.04 0.05 0.04 0.04
Debt-to-Capital Ratio
 0.03 0.04 0.05 0.04 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.18 1.16 1.16 1.23 1.29
Debt Service Coverage Ratio
 18.10 38.18 30.64 24.26 72.51
Interest Coverage Ratio
 44.64 45.46 26.29 83.18 86.12
Debt to Market Cap
 <0.01 0.00 0.00 <0.01 0.00
Interest Debt Per Share
 1.51 1.51 1.47 0.98 0.84
Net Debt to EBITDA
 -0.06 -2.34 -0.12 -0.14 -0.70
Profitability Margins
Gross Profit Margin
63.66%64.11%31.27%60.67%58.97%
EBIT Margin
18.80%15.98%14.68%14.82%12.36%
EBITDA Margin
22.06%19.01%15.50%15.38%13.08%
Operating Profit Margin
16.41%16.21%10.26%14.50%11.28%
Pretax Profit Margin
19.34%26.00%14.31%14.70%12.24%
Net Profit Margin
14.53%20.60%10.76%11.29%8.67%
Continuous Operations Profit Margin
14.53%20.60%10.76%11.29%8.67%
Net Income Per EBT
75.09%79.25%75.21%76.77%70.77%
EBT Per EBIT
117.90%160.41%139.55%101.39%108.54%
Return on Assets (ROA)
13.68%19.90%10.35%13.71%11.19%
Return on Equity (ROE)
17.60%23.07%11.99%16.82%14.41%
Return on Capital Employed (ROCE)
17.38%17.26%10.81%20.51%17.35%
Return on Invested Capital (ROIC)
12.89%13.59%8.08%15.60%12.43%
Return on Tangible Assets
18.83%28.74%10.35%13.70%11.35%
Earnings Yield
3.23%3.79%2.98%3.52%2.30%
Efficiency Ratios
Receivables Turnover
 12.48 20.39 19.06 11.34 13.12
Payables Turnover
 7.89 9.91 14.74 11.86 5.18
Inventory Turnover
 6.46 6.34 9.56 4.50 3.23
Fixed Asset Turnover
 34.40 30.41 22.44 9.75 9.73
Asset Turnover
 0.94 0.97 0.96 1.21 1.29
Working Capital Turnover Ratio
 3.34 1.70 1.32 2.16 2.68
Cash Conversion Cycle
 39.51 38.58 32.54 82.46 70.33
Days of Sales Outstanding
 29.25 17.90 19.15 32.18 27.83
Days of Inventory Outstanding
 56.53 57.53 38.16 81.06 112.96
Days of Payables Outstanding
 46.26 36.84 24.77 30.79 70.45
Operating Cycle
 85.78 75.43 57.31 113.24 140.79
Cash Flow Ratios
Operating Cash Flow Per Share
 3.76 8.21 5.30 7.12 0.85
Free Cash Flow Per Share
 3.75 8.16 5.26 7.07 0.78
CapEx Per Share
 0.01 0.05 0.04 0.05 0.07
Free Cash Flow to Operating Cash Flow
 1.00 0.99 0.99 0.99 0.92
Dividend Paid and CapEx Coverage Ratio
 1.47 4.07 2.63 146.90 0.51
Capital Expenditure Coverage Ratio
 251.79 158.91 141.80 146.90 11.97
Operating Cash Flow Coverage Ratio
 2.79 5.99 3.93 7.77 1.07
Operating Cash Flow to Sales Ratio
 0.09 0.21 0.17 0.20 0.03
Free Cash Flow Yield
1.90%3.76%4.64%6.10%0.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 30.93 26.40 33.53 28.41 43.57
Price-to-Sales (P/S) Ratio
 4.59 5.44 3.61 3.21 3.78
Price-to-Book (P/B) Ratio
 5.00 6.09 4.02 4.78 6.28
Price-to-Free Cash Flow (P/FCF) Ratio
 52.57 26.60 21.57 16.38 160.11
Price-to-Operating Cash Flow Ratio
 51.27 26.43 21.42 16.27 146.74
Price-to-Earnings Growth (PEG) Ratio
 -0.93 0.18 -2.01 0.68 4.05
Price-to-Fair Value
 5.00 6.09 4.02 4.78 6.28
Enterprise Value Multiple
 20.74 26.28 23.17 20.72 28.17
Enterprise Value
 12.88B 13.42B 7.49B 7.54B 8.02B
EV to EBITDA
 20.74 26.28 23.17 20.72 28.17
EV to Sales
 4.57 5.00 3.59 3.19 3.68
EV to Free Cash Flow
 52.40 24.43 21.46 16.28 156.23
EV to Operating Cash Flow
 52.20 24.27 21.31 16.17 143.18
Tangible Book Value Per Share
 26.09 22.92 28.23 24.26 19.62
Shareholders’ Equity Per Share
 38.56 35.63 28.23 24.26 19.98
Tax and Other Ratios
Effective Tax Rate
 0.25 0.21 0.25 0.23 0.29
Revenue Per Share
 42.94 39.90 31.44 36.14 33.22
Net Income Per Share
 6.24 8.22 3.38 4.08 2.88
Tax Burden
 0.75 0.79 0.75 0.77 0.71
Interest Burden
 1.03 1.63 0.97 0.99 0.99
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.06 0.26 0.02 0.02 0.05
Stock-Based Compensation to Revenue
 0.02 0.03 0.06 0.04 0.00
Income Quality
 0.34 1.00 1.57 1.34 0.20
Currency in INR